Protocol performance metrics and resource utilization of phase II investigator-initiated trials

被引:0
|
作者
Durivage, H.
Bridges, K. D.
Sauers, J.
Wellons, M.
Baker, L.
机构
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[3] Univ Minnesota, Masonic Can Ctr, Minneapolis, MN USA
[4] VCU Massey Canc Ctr, Richmond, VA USA
[5] Univ Texas Southwestern Simmons Canc Ctr, Dallas, TX USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.6066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6066
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Investigator-initiated pragmatic trials in developing countries - much needed but much ignored
    Shafiq, Nusrat
    Pandhi, Promila
    Malhotra, Samir
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (01) : 141 - 142
  • [42] Lessons learned from investigator-initiated clinical trials for localized pancreatic cancer
    Tsai, Susan
    Evans, Douglas B.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (01) : 69 - 74
  • [43] Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list
    Speich, Benjamin
    von Niederhaeusern, Belinda
    Blum, Claudine Angela
    Keiser, Jennifer
    Schur, Nadine
    Fuerst, Thomas
    Kasenda, Benjamin
    Christ-Crain, Mirjam
    Hemkens, Lars G.
    Pauli-Magnus, Christiane
    Schwenkglenks, Matthias
    Briel, Matthias
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2018, 96 : 73 - 83
  • [44] Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes
    Meador, Catherine B.
    Digumarthy, Subba R.
    Yeap, Beow Y.
    Hung, Yin P.
    Mino-Kenudson, Mari
    Farago, Anna F.
    Heist, Rebecca S.
    Marcoux, J. Paul
    Rangachari, Deepa
    Barbie, David A.
    Piotrowska, Zofia
    CLINICAL CANCER RESEARCH, 2025, 31 (01) : 25 - 34
  • [45] The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group
    Kim, Bum Jun
    Maeng, Chi Hoon
    Keam, Bhumsuk
    Im, Young-Hyuck
    Ro, Jungsil
    Jung, Kyung Hae
    Im, Seock-Ah
    Kim, Tae Won
    Lee, Jae Lyun
    Heo, Dae Seog
    Kim, Sang-We
    Park, Keunchil
    Ahn, Myung-Ju
    Cho, Byoung Chul
    Kim, Hoon-Kyo
    Kang, Yoon-Koo
    Cho, Jae Yong
    Yun, Hwan Jung
    Nam, Byung-Ho
    Zang, Dae Young
    CANCER RESEARCH AND TREATMENT, 2025, 57 (01): : 39 - 46
  • [46] Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN)
    Madeira, C.
    Pais, A.
    Kubiak, C.
    Demotes, J.
    Monteiro, E. C.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2016, 4 : 141 - 148
  • [47] Ohio CTSAs Implement a Reliant IRB Model for Investigator-Initiated Multicenter Clinical Trials
    Cola, Philip A.
    Reider, Carson
    Strassor, Jane E.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2013, 6 (03): : 176 - 178
  • [48] Phase I/II investigator-initiated study of olaparib and temozolomide in SCLC: Updated analysis and CNS outcomes.
    Meador, Catherine Belle
    Digumarthy, Subba
    Yeap, Beow Y.
    Farago, Anna F.
    Heist, Rebecca Suk
    Marcoux, J. Paul
    Rangachari, Deepa
    Barbie, David Allen
    Piotrowska, Zofia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Investigator-initiated Randomized Controlled Trials in Infectious Diseases: Better Value for Money for Registration Trials of New Antimicrobials
    Paul, Mical
    Harbarth, Stephan
    Huttner, Angela
    Thwaites, Guy E.
    Theuretzbacher, Ursula
    Bonten, Marc J. M.
    Leibovici, Leonard
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (07) : 1259 - 1264
  • [50] CHALLENGES AND EQUITY RELATED-ISSUES IN THE CONDUCT OF INVESTIGATOR-INITIATED CLINICAL TRIALS IN KIDNEY DISEASE
    Krishnasamy, Rathika
    Robison, Laura
    Howell, Martin
    Howard, Kirsten
    Reidlinger, Donna
    Shenoy, Aparna
    Mallard, Alistair
    Pascoe, Elaine
    Cho, Yeoungjee
    Viecelli, Andrea
    Roberts, Matthew
    Toussaint, Nigel
    Badve, Sunil
    Peh, Chen Au
    Irish, Ashley
    Johnson, Davidw
    Hawley, Carmel M.
    NEPHROLOGY, 2022, 27 : 43 - 44